AU5770786A - Human anti-inflammatory phospholipase inhibitor protein - Google Patents

Human anti-inflammatory phospholipase inhibitor protein

Info

Publication number
AU5770786A
AU5770786A AU57707/86A AU5770786A AU5770786A AU 5770786 A AU5770786 A AU 5770786A AU 57707/86 A AU57707/86 A AU 57707/86A AU 5770786 A AU5770786 A AU 5770786A AU 5770786 A AU5770786 A AU 5770786A
Authority
AU
Australia
Prior art keywords
human anti
inhibitor protein
phospholipase inhibitor
inflammatory
inflammatory phospholipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57707/86A
Inventor
Lorin F. Johnson
John P. Longenecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Partners Ltd
Original Assignee
Biotechnology Research Partners Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Partners Ltd filed Critical Biotechnology Research Partners Ltd
Publication of AU5770786A publication Critical patent/AU5770786A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AU57707/86A 1985-04-15 1986-04-14 Human anti-inflammatory phospholipase inhibitor protein Abandoned AU5770786A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72304685A 1985-04-15 1985-04-15
US723046 1985-04-15

Publications (1)

Publication Number Publication Date
AU5770786A true AU5770786A (en) 1986-11-05

Family

ID=24904592

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57707/86A Abandoned AU5770786A (en) 1985-04-15 1986-04-14 Human anti-inflammatory phospholipase inhibitor protein

Country Status (6)

Country Link
EP (1) EP0218696A4 (en)
JP (2) JP2757987B2 (en)
AU (1) AU5770786A (en)
CA (1) CA1290267C (en)
ES (1) ES8800691A1 (en)
WO (1) WO1986006100A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601676B2 (en) * 1985-01-10 1990-09-20 Biogen, Inc. Dna sequences recombinant dna molecules and processes for producing human lipocorton-like polypeptides
US5081019A (en) * 1985-01-10 1992-01-14 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides
US4950646A (en) * 1985-01-10 1990-08-21 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides
US4874743A (en) * 1985-01-10 1989-10-17 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
US4879224A (en) * 1985-01-10 1989-11-07 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
JPS6256429A (en) * 1985-09-04 1987-03-12 Teijin Ltd Protein having phospholipase a2 inhibiting activity
PT87083B (en) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int A PROCESS FOR THE PREPARATION OF A VASCULAR ANTICOAGULANT PROTEIN, OF DNA THAT CODIFIES FOR THIS PROTEIN AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING IT
JPH06799B2 (en) * 1987-04-02 1994-01-05 帝人株式会社 A protein having an inhibitory activity on a respiratory phosphatase lipase A (2)
DE68923107T2 (en) * 1988-02-26 1996-01-18 Biogen Inc DNA sequences, recombinant DNA molecules and methods for the production of lipocortin III, IV, V, and VI.
DE69033653T2 (en) * 1989-04-07 2001-06-07 Cancerforskningsfonden Af 1989 UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
WO1991001999A1 (en) * 1989-08-03 1991-02-21 Teijin Limited Phospholipase a2 inhibiting protein originating in inflamed region, production thereof, and gene therefor
US5344764A (en) * 1989-08-03 1994-09-06 Teijin Limited Protein inhibitors of phospholipase A2 purified from inflammatory sites and production process
WO1991003544A1 (en) * 1989-08-29 1991-03-21 The Regents Of The University Of California Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
US6248715B1 (en) 1993-06-01 2001-06-19 Chiron Corporation Method of treating a urokinase-type plasminogen activator-mediated disorder
AU7137994A (en) 1993-06-01 1994-12-20 Chiron Corporation Expression of urokinase plasminogen activator inhibitors
WO1998042733A1 (en) * 1997-03-20 1998-10-01 Fondazione Centro San Raffaele Del Monte Tabor uPAR MIMICKING PEPTIDE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601676B2 (en) * 1985-01-10 1990-09-20 Biogen, Inc. Dna sequences recombinant dna molecules and processes for producing human lipocorton-like polypeptides
JPS6256429A (en) * 1985-09-04 1987-03-12 Teijin Ltd Protein having phospholipase a2 inhibiting activity

Also Published As

Publication number Publication date
ES553961A0 (en) 1987-11-16
JPS63500561A (en) 1988-03-03
JPH08187087A (en) 1996-07-23
ES8800691A1 (en) 1987-11-16
CA1290267C (en) 1991-10-08
EP0218696A4 (en) 1989-08-16
EP0218696A1 (en) 1987-04-22
JP2637709B2 (en) 1997-08-06
WO1986006100A1 (en) 1986-10-23
JP2757987B2 (en) 1998-05-25

Similar Documents

Publication Publication Date Title
AU581462B2 (en) Surgical instrument
AU621923B2 (en) Microdilatation probe
AU6734987A (en) Treatment of emulsions
AU5450186A (en) Surgical device
AU583592B2 (en) Protein hydrolysates for pharmaceutical use
AU5770786A (en) Human anti-inflammatory phospholipase inhibitor protein
AU5730286A (en) Treatment of factor viii inhibitors
AU1928688A (en) Tissue factor inhibitor
AU590016B2 (en) Peptides
AU5463286A (en) Photoconductor
AU1545288A (en) Phospholipase a2 inhibitors
AU5224286A (en) Spiro-dioxolanes, - dithiolanes and-oxothiolanes
AU5296486A (en) Lipoxygenase inhibitors
AU569433B2 (en) Photometric determination of protein c
AU2927489A (en) Phospholipase a2 inhibitors
AU5476486A (en) Surgical stapling instrument
AU578779B2 (en) Cosmetics
AU7851687A (en) Anti-inflammatory peptides
AU6463986A (en) Dopamine-beta-hydroxylase inhibitors
AU1258988A (en) Esters of oxalofluoride
AU5831286A (en) Human laminin
AU5908386A (en) Ankle support
AU5603786A (en) Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
AU590538B2 (en) Dopamine-beta-hydroxylase inhibitors
AU6164786A (en) Cyclohexanealkanoic acids